U.S. Food and Drug Administration Financial Analyst Salaries in Boulder
The average U.S. Food and Drug Administration Financial Analyst in Boulder earns an estimated $77,527 annually, which includes an estimated base salary of $71,194 with a $6,333 bonus. U.S. Food and Drug Administration's Financial Analyst compensation is $9,873 less than the US average for a Financial Analyst. Financial Analyst salaries at U.S. Food and Drug Administration in Boulder can range from $57,500 - $86,000.
In Boulder, The Finance Department at U.S. Food and Drug Administration earns $5,324 more on average than the Operations Department.
Last updated 3 years ago.
- $71,194
- avg. base
- $6,333
- avg. bonus
Financial Analyst Salaries at U.S. Food and Drug Administration
In Boulder, Financial Analysts earn $3,239 more than Financial Analysts, and $2,657 less than Business Analysts.
Compensation at U.S. Food and Drug Administration by Department
In Boulder, The Finance Department averages $5,324 more than the Operations Department, and $15,581 less than the Sales Department
Financial Analyst Compensation by Gender (All Companies)
The average female Financial Analyst at companies similar size to U.S. Food and Drug Administration reported making $93,556, while the average male Financial Analyst at similar sized companies reported making $91,853.
Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Financial Analyst at companies similar size to U.S. Food and Drug Administration reported making $98,729, while the average Native American Financial Analyst at similar sized companies reported making $60,000.
How Financial Analysts at U.S. Food and Drug Administration Rate Their Compensation
The majority of Financial Analysts at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Financial Analysts at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
